This inventor holds 1 USPTO granted patent. Top assignee: Institut Pasteur. Active years: 2004.
Company Filing History:
Years Active: 2004
Title: Michel Golberg: Innovator in Therapeutic Peptides
Introduction
Michel Golberg is a prominent inventor based in Paris, France. He has made significant contributions to the field of therapeutic agents through his innovative work on peptides. His research focuses on the development of new peptides derived from IL-2, which have potential applications in medicine.
Latest Patents
Michel Golberg holds a patent for "Peptides of IL-2 and derivatives thereof and their use as therapeutic agents." This invention relates to novel peptides of IL-2 and their derivatives, highlighting their potential as therapeutic agents. The patent showcases his commitment to advancing medical science and improving treatment options.
Career Highlights
Michel Golberg is affiliated with the prestigious Institut Pasteur, where he conducts his research. His work at this renowned institution underscores his dedication to scientific innovation and the development of new therapeutic solutions.
Collaborations
Michel collaborates with esteemed colleagues, including Jacques Theze and Ralph Eckenberg. These partnerships enhance the research environment and contribute to the advancement of their shared goals in the field of therapeutic peptides.
Conclusion
Michel Golberg's contributions to the field of therapeutic peptides exemplify his innovative spirit and commitment to improving healthcare. His work at the Institut Pasteur and his patent on IL-2 derivatives highlight his role as a key figure in medical research.